PRIMECAP MANAGEMENT CO/CA/ - Q2 2021 holdings

$149 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 333 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 23.1% .

 Value Shares↓ Weighting
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$3,545,767,000
+3.5%
15,635,272
+3.4%
2.38%
-0.3%
WFC BuyWELLS FARGO CO NEW$2,258,576,000
+16.3%
49,869,195
+0.3%
1.52%
+12.0%
INTC BuyINTEL CORP$1,960,328,000
-10.5%
34,918,555
+2.1%
1.32%
-13.8%
BIDU BuyBAIDU INCspon adr rep a$1,936,089,000
-5.7%
9,495,285
+0.6%
1.30%
-9.1%
SPLK BuySPLUNK INC$992,853,000
+29.0%
6,867,151
+20.9%
0.67%
+24.2%
RJF BuyRAYMOND JAMES FINL INC$781,532,000
+16.6%
6,016,415
+10.0%
0.52%
+12.4%
ZBH BuyZIMMER BIOMET HOLDINGS INC$579,031,000
+3.1%
3,600,490
+2.6%
0.39%
-0.8%
OLED BuyUNIVERSAL DISPLAY CORP$506,381,000
-5.1%
2,277,609
+1.0%
0.34%
-8.6%
LIVN BuyLIVANOVA PLC$338,436,000
+14.1%
4,023,725
+0.0%
0.23%
+9.7%
FGEN BuyFIBROGEN INC$334,035,000
-18.2%
12,543,548
+6.6%
0.22%
-21.4%
XPEV BuyXPENG INCads$295,245,000
+86.8%
6,646,677
+53.5%
0.20%
+80.0%
LYFT BuyLYFT INC$254,133,000
+3.3%
4,201,931
+7.9%
0.17%
-0.6%
POLY BuyPLANTRONICS INC NEW$254,017,000
+7.5%
6,087,150
+0.3%
0.17%
+3.6%
MKTX BuyMARKETAXESS HLDGS INC$197,517,000
+6.3%
426,060
+14.2%
0.13%
+2.3%
WEX BuyWEX INC$155,074,000
+30.9%
799,764
+41.2%
0.10%
+25.3%
CSX BuyCSX CORP$135,775,000
-11.4%
4,232,400
+166.3%
0.09%
-15.0%
NTNX BuyNUTANIX INCcl a$133,460,000
+45.9%
3,491,885
+1.4%
0.09%
+40.6%
DLTR BuyDOLLAR TREE INC$134,410,000
+15.3%
1,350,850
+32.6%
0.09%
+11.1%
EPZM BuyEPIZYME INC$127,039,000
-4.3%
15,287,477
+0.3%
0.08%
-8.6%
RYTM BuyRHYTHM PHARMACEUTICALS INC$120,489,000
-5.7%
6,153,691
+2.5%
0.08%
-9.0%
SYY BuySYSCO CORP$114,697,000
+21.0%
1,475,200
+22.6%
0.08%
+16.7%
ALLO BuyALLOGENE THERAPEUTICS INC$93,289,000
+102.4%
3,577,030
+174.0%
0.06%
+96.9%
FIS BuyFIDELITY NATL INFORMATION SV$92,426,000
+2.2%
652,400
+1.4%
0.06%
-1.6%
LYV BuyLIVE NATION ENTERTAINMENT IN$91,381,000
+4.0%
1,043,285
+0.5%
0.06%0.0%
TTWO BuyTAKE-TWO INTERACTIVE SOFTWAR$89,142,000
+4.2%
503,570
+4.0%
0.06%0.0%
LUNG BuyPULMONX CORP$86,446,000
+58.6%
1,959,343
+64.4%
0.06%
+52.6%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$71,746,000
+23.8%
1,348,610
+1.0%
0.05%
+20.0%
LVS BuyLAS VEGAS SANDS CORP$61,747,000
-13.1%
1,171,900
+0.3%
0.04%
-18.0%
SWN BuySOUTHWESTERN ENERGY CO$60,087,000
+22.5%
10,597,325
+0.5%
0.04%
+17.6%
RNG BuyRINGCENTRAL INCcl a$53,743,000
-2.3%
184,950
+0.1%
0.04%
-5.3%
GAN BuyGAN LTD$45,531,000
+131.0%
2,769,532
+155.7%
0.03%
+121.4%
XPO BuyXPO LOGISTICS INC$45,366,000
+30.8%
324,300
+15.3%
0.03%
+25.0%
LASR BuyNLIGHT INC$43,083,000
+12.6%
1,187,524
+0.6%
0.03%
+7.4%
TPTX BuyTURNING POINT THERAPEUTICS I$40,692,000
-7.7%
521,560
+11.9%
0.03%
-12.9%
ARLO BuyARLO TECHNOLOGIES INC$36,797,000
+20.1%
5,435,270
+11.4%
0.02%
+19.0%
GKOS BuyGLAUKOS CORP$37,707,000
+3.0%
444,500
+1.9%
0.02%
-3.8%
MSGE BuyMADISON SQUARE GRDN ENTERTNMcl a$35,855,000
+103.1%
427,001
+97.8%
0.02%
+100.0%
MAXR BuyMAXAR TECHNOLOGIES INC$35,818,000
+16.3%
897,240
+10.2%
0.02%
+14.3%
AMBA BuyAMBARELLA INC$33,930,000
+14.2%
318,200
+7.5%
0.02%
+9.5%
XMTR NewXOMETRY INC$26,217,000300,000
+100.0%
0.02%
BBIO BuyBRIDGEBIO PHARMA INC$27,241,000
+24.5%
446,860
+25.8%
0.02%
+20.0%
CALA BuyCALITHERA BIOSCIENCES INC$21,618,000
-13.6%
10,343,700
+0.1%
0.02%
-11.8%
DOOR BuyMASONITE INTL CORP$21,598,000
+8.0%
193,200
+11.4%
0.02%
+7.1%
EAT NewBRINKER INTL INC$21,722,000351,200
+100.0%
0.02%
ZI BuyZOOMINFO TECHNOLOGIES INC$16,895,000
+8.3%
323,839
+1.5%
0.01%0.0%
DHR NewDANAHER CORPORATION$16,645,00062,026
+100.0%
0.01%
CYBR BuyCYBERARK SOFTWARE LTD$13,294,000
+9.8%
102,050
+9.0%
0.01%
+12.5%
HCAT BuyHEALTH CATALYST INC$12,935,000
+24.6%
233,015
+5.0%
0.01%
+28.6%
ADPT BuyADAPTIVE BIOTECHNOLOGIES COR$8,969,000
+5.8%
219,500
+4.3%
0.01%0.0%
OMCL BuyOMNICELL COM$8,199,000
+89.4%
54,137
+62.4%
0.01%
+100.0%
HUM NewHUMANA INC$6,954,00015,708
+100.0%
0.01%
NGVT BuyINGEVITY CORP$8,136,000
+119.8%
100,000
+104.1%
0.01%
+66.7%
TUEM NewTUESDAY MORNING CORP$7,110,0001,580,000
+100.0%
0.01%
TSP NewTUSIMPLE HLDGS INCcl a$7,138,000100,200
+100.0%
0.01%
RGEN NewREPLIGEN CORP$4,669,00023,387
+100.0%
0.00%
SAFE BuySAFEHOLD INC$4,624,000
+407.6%
58,900
+353.1%
0.00%
+200.0%
AUD NewAUDACY INCcl a$3,984,000924,300
+100.0%
0.00%
JAMF NewJAMF HLDG CORP$2,400,00071,500
+100.0%
0.00%
SNCY BuySUN CTRY AIRLS HLDGS INC$3,290,000
+10.6%
88,900
+2.4%
0.00%0.0%
JELD BuyJELD-WEN HLDG INC$3,122,000
+290.2%
118,900
+311.4%
0.00%
+100.0%
ZM BuyZOOM VIDEO COMMUNICATIONS INcl a$1,587,000
+30.8%
4,100
+8.6%
0.00%0.0%
OGN NewORGANON & CO$1,586,00052,420
+100.0%
0.00%
ULCC NewFRONTIER GROUP HLDGS INC$954,00056,000
+100.0%
0.00%
PDAC NewPERIDOT ACQUISITION CORP$448,00036,800
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LILLY ELI & CO42Q3 202310.5%
BIOGEN INC.42Q3 20236.8%
AMGEN INC.42Q3 20235.3%
MICROSOFT CORP.42Q3 20234.2%
ADOBE SYSTEMS INCORPORATED42Q3 20234.1%
TEXAS INSTRS. INC.42Q3 20233.5%
FEDEX CORP42Q3 20233.3%
SOUTHWEST AIRLS CO42Q3 20233.8%
NOVARTIS AG ADR42Q3 20232.7%
MICRON TECHNOLOGY INC42Q3 20232.8%

View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.

Latest significant ownerships (13-D/G)
PRIMECAP MANAGEMENT CO/CA/ Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NEKTAR THERAPEUTICSJuly 07, 20238,149,8764.3%
STANDARD BIOTOOLS INC.July 07, 20233,220,9174.1%
Calithera Biosciences, Inc.February 09, 2023401,0808.2%
CERUS CORPJanuary 09, 20238,849,6005.0%
COMSCORE, INC.January 09, 20232,883,4353.1%
STRATASYS LTD.December 08, 20223,176,4994.8%
Wave Life Sciences Ltd.December 08, 20224,225,9084.9%
NN INCNovember 09, 20221,763,6404.0%
AXCELIS TECHNOLOGIES INCOctober 07, 20221,649,4665.0%
Epizyme, Inc.Sold outSeptember 08, 202200.0%

View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G/A2024-02-12

View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.

Compare quarters

Export PRIMECAP MANAGEMENT CO/CA/'s holdings